Target intelligence / Profile preview

Hemidesmosome protein

Molecular classification
Other
01

Overview

Hemidesmosome proteins are not a single target or molecule but refer collectively to a group of multiprotein complexes critical for cell-extracellular matrix adhesion, especially in epithelial tissues[1][2][3][5][6]. Their key components include integrin α6β4, plectin, BP180 (collagen XVII), BP230, and the tetraspanin CD151, which together form anchor points linking the basal keratin cytoskeleton to the basement membrane[1][2][3][5][6]. These proteins are essential for tissue resilience, mechanical stability, and integrity of epithelial layers, and disruptions can lead to severe blistering diseases and contribute to tumor progression and invasion[3][4][5][6]. The entry as "Hemidesmosomal and Extracellular Matrix Proteins" is overly broad and refers to a functional class rather than a specific target; thus, it is not suitable as a canonical drug target. Note: - The provided name is not a specific molecule or receptor, but a descriptive phrase for a class of structural and matrix proteins. There is no single target with this name. - Proper categorization would require specifying individual proteins, such as "Integrin α6β4" or "Plectin."[1][3][6]

Other names
Hemidesmosomal proteinExtracellular matrix proteinHD protein
02

Biological functions

Cell adhesionCytoskeletal linkageSignal transduction (indirect via integrins)Maintenance of tissue integrity
03

Disease associations

Blistering skin disorders (e.g., epidermolysis bullosa, bullous pemphigoid)CancerWound healing defects
04

Safety considerations

Autoimmune targeting (causing blistering disorders)Tissue fragility
05

Biomarkers

BP180 (bullous pemphigoid antigen 2)BP230 (bullous pemphigoid antigen 1)Integrin α6β4

Beyond the preview

Go deeper on Hemidesmosome protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemidesmosome protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call